Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Acamprosate for Preventing Alcohol Relapse Among Alcohol Dependent Drug Treatment Court Participants

NCT00249379 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT00249379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00249379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Acamprosate for Preventing Alcohol Relapse Among Alcohol Dependent Drug Treatment Court Participants
Lead sponsor
Virginia Commonwealth University
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2005
Completion date
August 31, 2008
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence